Avalon
Log In
Contact
Article

What is Lab Benefit Management?

How Health Plans Control
Diagnostic Costs

Healthcare costs rarely rise in dramatic bursts. More often, they creep upward through thousands of small inefficiencies hiding in plain sight. Laboratory testing is one of them.

Over the past decade, diagnostic testing has exploded in complexity and volume. From routine blood panels to advanced molecular diagnostics, providers now have access to an unprecedented number of tests. The problem is that more testing does not always mean better care.

Unnecessary or duplicative lab tests can trigger false positives, additional procedures, delayed treatment decisions, and avoidable patient anxiety. For health plans already managing rising medical costs, uncontrolled diagnostic utilization has become both a clinical and financial risk.

That is where Laboratory Benefit Management (LBM) comes in.

Laboratory benefit management helps health plans ensure patients receive the right test at the right time for the right reason. By combining evidence-based guidelines, utilization management, analytics, and provider collaboration, LBM programs reduce unnecessary spending while improving diagnostic quality and patient outcomes.

What Is Laboratory Benefit Management?

Laboratory Benefit Management is a specialized approach to managing laboratory testing across the healthcare ecosystem. Health plans use LBM programs to evaluate whether diagnostic tests are clinically necessary, cost-effective, and aligned with evidence-based care standards.

Unlike traditional utilization management, which often focuses broadly on medical services, LBM targets the rapidly evolving world of diagnostics. That distinction matters. Modern lab testing now includes high-cost genetic panels, molecular diagnostics, and precision medicine tools that require far more sophisticated oversight.

The goal is not to restrict access to care. It is to improve diagnostic accuracy while reducing waste.

A comprehensive LBM program typically includes:

  • Evidence-based policy management
  • Automated enforcement technology
  • Prior authorization for select tests such as genetics
  • Laboratory network optimization
  • Provider education
  • Utilization analytics
  • Decision-support technology

Why Diagnostic Spending Keeps Rising

Diagnostic testing represents a relatively small share of total healthcare spending, but it influences a massive percentage of clinical decisions. Every unnecessary test creates downstream consequences.

Several forces are driving higher laboratory costs:

  • Increased use of genetic and molecular testing
  • Greater complexity in test selection
  • Defensive medicine practices
  • Duplicate testing across providers
  • Limited transparency around pricing and clinical utility

10-20%

reduced outpatient laboratory spending with effective LBM programs

In many cases, providers operate in a fragmented system where thousands of tests are available, but guidance is inconsistent. One physician may order a targeted diagnostic panel, while another orders a broader and significantly more expensive version of the same test.

For health plans, those variations scale quickly across large member populations.

Effective LBM programs can help reduce outpatient laboratory spending by an estimated 10% to 20%, particularly when unnecessary or low-value testing is identified early.

 How Laboratory Benefit Management Works

Strong LBM programs combine clinical oversight with real-time decision support.

Evidence-Based Laboratory Guidelines

At the center of LBM are clinical appropriateness rules grounded in medical research and specialty society recommendations. These guidelines help ensure tests are ordered only when medically necessary and likely to improve patient care.

This approach reduces low-value testing while encouraging more consistent care delivery.

Prior Authorization and Utilization Review

Certain high-cost or highly specialized tests, such as genetic tests, may require prior authorization. While often misunderstood as a barrier, this process helps confirm that the selected test matches the patient’s condition and clinical history.

The result is fewer duplicate tests, fewer unnecessary procedures, and more efficient use of healthcare resources.

Laboratory Network Optimization

LBM programs also help health plans guide testing toward high-quality, cost-efficient laboratories. That reduces out-of-network leakage and improves consistency in turnaround times and reporting standards.

Advanced Analytics and Machine Learning

Modern LBM extends far beyond utilization control. Advanced analytics platforms can identify testing trends across entire populations and detect patterns associated with chronic disease development.

For example, machine learning tools leveraging robust diagnostic data may identify patients at elevated risk for diabetes, kidney disease, or hereditary cancer syndromes earlier in the care journey. That allows health plans and providers to intervene sooner, often before conditions become more severe and expensive to treat.

In that sense, modern LBM increasingly functions as a population health strategy rather than a simple cost-management tool.

How LBM Improves Patient Outcomes

Cost containment alone does not sustain an LBM program. Clinical value does.

Unnecessary testing can expose patients to a cascade of avoidable stress. A false positive result may lead to imaging, biopsies, specialist visits, or invasive procedures that ultimately provide no clinical benefit.

By eliminating low-value or duplicative testing, LBM helps patients avoid those downstream consequences.

At the same time, better diagnostic guidance can improve early detection and disease management. Standardized testing pathways help providers select more accurate tests sooner, which may accelerate diagnosis and treatment decisions.

Patients also benefit from more consistent care experiences. When evidence-based guidelines shape diagnostic decisions, care becomes less dependent on geographic variation or individual ordering habits.

Why Transparency
Matters

Healthcare consumers increasingly expect the same transparency they receive in other industries. Diagnostic testing has historically lagged behind.

Many patients never know:

  • Why a test was ordered
  • Whether alternatives exist
  • What the test will cost
  • Whether the test is clinically necessary

LBM programs help create greater visibility into both cost and clinical value. That transparency supports more informed decisions for providers, health plans, and patients alike.

It also matters financially. With high deductibles and growing out-of-pocket costs, unnecessary testing directly affects members. Every avoidable lab order has the potential to become an avoidable bill.

The Future of Laboratory
Benefit Management

Diagnostic medicine is entering a new era shaped by precision medicine, genomics, and predictive analytics. As testing grows more sophisticated, health plans will need smarter systems to manage clinical appropriateness at scale.

Future-focused LBM programs will rely increasingly on:

  • Artificial intelligence
  • Predictive population health analytics
  • Real-time provider decision support
  • Integrated clinical and claims data

The organizations that succeed will not simply reduce testing volume. They will use diagnostic intelligence to improve outcomes while controlling costs.

How Avalon Supports
Smarter Laboratory Benefit Management

Avalon Healthcare Solutions helps health plans modernize laboratory benefit management through evidence-based policies, advanced analytics, and provider collaboration.

By combining clinical expertise with data-driven insights, Avalon helps payers reduce unnecessary laboratory spending while improving transparency, diagnostic quality, and member outcomes.

As laboratory testing continues to evolve, effective LBM is becoming essential infrastructure for sustainable healthcare management. The challenge is no longer whether health plans should manage diagnostic utilization. It is whether they can afford not to.